Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fibrinolytic therapy

A V Persson, F T Padberg, V E Dyer

    Comprehensive Therapy
    |November 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Fibrinolytic therapy offers an effective treatment for fibrin-based clots, comparable in safety to heparin. It not only halts thrombosis but also restores normal blood flow, preventing long-term complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is There an Accurate Pre-operative Criterion for Dialysis Access Artery or Vein diameter?

    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2017
    Same author

    Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.

    Journal of vascular surgery·2001
    Same author

    In-stent restenosis after carotid angioplasty-stenting: incidence and management.

    Journal of vascular surgery·2001
    Same author

    Venous severity scoring: An adjunct to venous outcome assessment.

    Journal of vascular surgery·2000
    Same author

    Mandibular subluxation for distal internal carotid exposure: technical considerations.

    Journal of vascular surgery·1999
    Same author

    Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production.

    Journal of vascular surgery·1999
    Same journal

    Heparin-induced thrombocytopenia and thrombosis.

    Comprehensive therapy·2011
    Same journal

    Antiplatelet therapy in cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Genetics of cardiovascular disease.

    Comprehensive therapy·2011
    Same journal

    Septic renal vein thrombosis complicated by septic pulmonary embolism.

    Comprehensive therapy·2011
    Same journal

    Gout and hyperuricemia.

    Comprehensive therapy·2011
    Same journal

    Problems with computerized health records.

    Comprehensive therapy·2011
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Thrombosis and Hemostasis

    Background:

    • Fibrin-based intraluminal clots are a common clinical challenge.
    • Existing treatments like heparin primarily halt the thrombotic process.

    Purpose of the Study:

    • To highlight the benefits of fibrinolytic therapy as a treatment for fibrin-based clots.
    • To compare the safety and efficacy of fibrinolytic therapy with heparin.

    Main Methods:

    • Review of clinical applications of fibrinolytic agents.
    • Emphasis on patient selection, dosage, and monitoring protocols.
    • Comparison of outcomes with standard anticoagulant therapy (heparin).

    Main Results:

    • Fibrinolytic therapy demonstrates a complication incidence similar to heparin when used appropriately.

    Related Experiment Videos

  • Fibrinolytic agents not only inhibit thrombosis but also restore hemodynamic function.
  • Patients treated with fibrinolytic therapy avoid long-term sequelae such as amputation and postphlebitic syndrome.

    • Conclusions:

    • Fibrinolytic therapy is a valuable and safe addition to the clinician's toolkit for managing thrombotic events.
    • The therapy's ability to reestablish normal hemodynamics offers superior patient outcomes compared to heparin alone.